Ultra-early response assessment in lymphoma treatment: [18F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment

Purpose To determine whether, in patients with Hodgkin lymphoma (HL) or non-Hodgkin lymphoma (NHL), [ 18 F]FDG PET/MR can capture treatment effects within the first week after treatment initiation, and whether changes in glucose metabolism and cell density occur simultaneously. Methods Patients with...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of nuclear medicine and molecular imaging 2018-06, Vol.45 (6), p.931-940
Hauptverfasser:	Mayerhoefer, Marius E., Raderer, Markus, Jaeger, Ulrich, Staber, Philipp, Kiesewetter, Barbara, Senn, Daniela, Gallagher, Ferdia A., Brindle, Kevin, Porpaczy, Edit, Weber, Michael, Berzaczy, Dominik, Simonitsch-Klupp, Ingrid, Sillaber, Christian, Skrabs, Cathrin, Haug, Alexander
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiology Cell Count Cell density Chemotherapy Covariance matrix Density Female Fluorine isotopes Fluorodeoxyglucose F18 Germany Glucose Glucose metabolism Hodgkin Disease - diagnostic imaging Humans Imaging Immunotherapy Lesions Lymphoma Lymphoma, Non-Hodgkin - diagnostic imaging Magnetic Resonance Imaging Medicine Medicine & Public Health Metabolism Nuclear Medicine Oncology Original Article Orthopedics Patients Positron-Emission Tomography Pregnancy Prospective Studies Radiology Radiopharmaceuticals Statistical analysis Tomography, X-Ray Computed Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!